Coherus Oncology (CHRS) FCF Margin Growth (3y) (2016 - 2026)
Coherus Oncology (CHRS) FCF Margin Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15,064.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 723.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1,409.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Coherus Oncology | 195.05 Mn | 28.00 Mn | 8.50 Mn | -25,787.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25,787.00 |
| Dec 31, 2025 | 22.00 |
| Sep 30, 2025 | -31,782.00 |
| Jun 30, 2025 | 434,414.00 |
| Mar 31, 2025 | -31,104.00 |
| Dec 31, 2024 | 44,192.00 |
| Sep 30, 2024 | -104,102.00 |
| Jun 30, 2024 | 96,936.00 |
| Mar 31, 2024 | 611,018.00 |
| Dec 31, 2023 | -4,331.00 |
| Sep 30, 2023 | -11,266.00 |
| Jun 30, 2023 | -10,905.00 |
| Mar 31, 2023 | -22,243.00 |
| Dec 31, 2022 | -23,382.00 |
| Sep 30, 2022 | -13,187.00 |
| Jun 30, 2022 | -9,962.00 |
| Mar 31, 2022 | 6,358.00 |
| Jun 30, 2020 | 408,082.00 |
| Mar 31, 2020 | 4.66 Mn |
| Dec 31, 2019 | 1.11 Mn |